Study shows neutralizing capacity of monoclonal antibodies against SARS-CoV-2 variants of concern

By | November 18, 2021
Canadian public health researchers recently published a study in the journal Antiviral Research wherein they described generating a panel of murine hybridomas recognizing SARS-CoV-2 spike protein or nucleoprotein, capable of neutralizing the SARS-CoV-2 variants of concern, proving their therapeutic potential.